The Association Between Mitochondrial tRNA Glu Variants and Hearing Loss: A Case-Control Study

• Published in: Pharmacogenomics and personalized medicine Vol. 17; p. 77
• Main Authors: Yu, Xuejiao, Li, Sheng, Guo, Qinxian, Leng, Jianhang, Ding, Yu
• Format: Journal Article
• Language: English
• Published: New Zealand 2024
• Subjects: pediatrics; mitochondrial tRNAGlu variants; deafness; tRNA metabolism
• ISSN: 1178-7066; 1178-7066

This study aimed to examine the frequencies of mt-tRNA variants in 180 pediatric patients with non-syndromic hearing loss (NSHL) and 100 controls. Sanger sequencing was performed to screen for mt-tRNA variants. These mitochondrial DNA (mtDNA) pathogenic mutations were further assessed using phylogenetic conservation and haplogroup analyses. We also traced the origins of the family history of probands carrying potential pathogenic mtDNA mutations. Mitochondrial functions including mtDNA content, ATP and reactive oxygen species (ROS) were examined in cells derived from patients carrying the mt-tRNA A14692G and CO1/tRNA G7444A variants and controls. We identified four possible pathogenic variants: m.T14709C, m.A14683G, m.A14692G and m.A14693G, which were found in NSHL patients but not in controls. Genetic counseling suggested that one child with the m.A14692G variant had a family history of NSHL. Sequence analysis of mtDNA suggested the presence of the CO1/tRNA G7444A and mt-tRNA A14692G variants. Molecular analysis suggested that, compared with the controls, patients with these variants exhibited much lower mtDNA copy numbers, ATP production, whereas ROS levels increased ( <0.05 for all), suggesting that the m.A14692G and m.G7444A variants led to mitochondrial dysfunction. mt-tRNA variants are important risk factors for NSHL.